Clinical Trial: Ladarixin With Sotorasib in Advanced NSCLC
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Study Type: INTERVENTIONAL
Official Title: Phase I/II Study of Ladarixin and Sotorasib in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer (NSCLC)
Brief Summary:
This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced KRASG12C mutant non-small cell lung cancer (NSCLC).
Read more